Results 321 to 330 of about 860,286 (378)

Importance of the (Pro)renin Receptor in Activating the Renin-Angiotensin System During Normotensive and Preeclamptic Pregnancies. [PDF]

Curr Hypertens Rep
Schofield LG, Endacott SK, Delforce SJ, Lumbers ER, Pringle KG.   +4 more
europepmc   +1 more source

Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. [PDF]

Cells
Lozinski M, Lumbers ER, Bowden NA, Martin JH, Fay MF, Pringle KG, Tooney PA.   +6 more
europepmc   +1 more source

Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians. [PDF]

Mol Cell Biochem
Afsar B, Afsar RE, Caliskan Y, Lentine KL, Edwards JC.   +4 more
europepmc   +1 more source

Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins). [PDF]

J Manag Care Spec Pharm
Cheruvu SS, Fatima B, Abughosh S.
europepmc   +1 more source

Cost-effectiveness analysis of targeted-release formulation of budesonide (Tarpeyo) in conjunction with optimized renin-angiotensin system inhibitor (RASi) therapy relative to optimized RASi therapy alone for adults with primary immunoglobulin A nephropathy in the United States. [PDF]

J Manag Care Spec Pharm
Yaghoubi M, Jiang H, Casciano R, Ngai C, Patel M.   +4 more
europepmc   +1 more source

Health Care Spending After Initiating Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure Treatment.

JAMA Health Forum
Hwang CS, Desai RJ, Kesselheim AS, Levin R, Kattinakere Sreedhara S, Rome BN.   +5 more
europepmc   +1 more source

Does glycaemic control or renal function provide a better indicator for the service support required in type 1 diabetes?

Diabetic Medicine, EarlyView.
Adrian H. Heald, Mike Stedman, Edward Jude, Hellena Habte‐Asres, Angus Forbes, Martin Whyte, J. Martin Gibson, William Ollier   +7 more
wiley   +1 more source

Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.

JAMA
Legrand M, Falcone J, Cholley B, Charbonneau H, Delaporte A, Lemoine A, Garot M, Joosten A, Meistelman C, Cheron-Leroy D, Rives JP, Pastene B, Dewitte A, Sigaut S, Danguy des Deserts M, Truc C, Boisson M, Lasocki S, Cuvillon P, Schiff U, Jaber S, Le Guen M, Caillard A, Bar S, Pereira de Souza Neto E, Colas V, Dimache F, Girardot T, Jozefowicz E, Viquesnel S, Berthier F, Vicaut E, Gayat E, Stop-or-Not Trial Group.   +33 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Renin-Angiotensin System

Annual Review of Physiology, 1978
Since the discovery of renin 80 years ago, there have been remarkable advances in our understanding of the renin-angiotensin system. The system as it is known today is summarized in Figure 1. Angiotensin III, the active component of the system, has several important physiological actions.
W F Ganong, B J Morris, I A Reid
openaire   +3 more sources